GlassScriptPhysician profile
Kerith L Lucco
NPI 1588780662
$2,473.90
in general payments reported to CMS, 2019-2025
30 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $161 · 2021: $305 · 2022: $408 · 2023: $553 · 2024: $412 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $391.44 | 2023-2025 | Veozah |
| Abbvie INC. | $365.39 | 2019-2024 | |
| Organon LLC | $206.43 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $173.07 | 2021-2022 | |
| Agile Therapeutics, INC. | $134.04 | 2021-2023 | Twirla |
| Sumitomo Pharma America, INC. | $132.80 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $127.96 | 2019-2023 | Gardasil 9 |
| Evofem Biosciences, INC. | $123.58 | 2021-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $112.41 | 2019-2024 | |
| Roche Diagnostics Corporation | $92.08 | 2019 | |
| Exeltis, USA INC. | $90.93 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $58.70 | 2022-2025 | Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $49.90 | 2021 | |
| Meditrina | $46.99 | 2022-2023 | |
| Exact Sciences Corporation | $43.65 | 2024 | Cologuard Collection Kit |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $34.79 | 2019-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $31.87 | 2019-2020 | |
| Avion Pharmaceuticals | $31.35 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $28.91 | 2019 | |
| Lupin INC. | $24.16 | 2019 | |
| Karl Storz Endoscopy-America | $22.07 | 2020 | |
| Daiichi Sankyo INC. | $19.37 | 2021 | |
| Dexcom, INC. | $19.10 | 2024 | Dexcom G6 Transmitter |
| Impel Pharmaceuticals INC. | $18.27 | 2022 | |
| Allergan, INC. | $17.43 | 2019 | |
| Medtronic, INC. | $16.85 | 2023 | V-Loc 180 |
| Pfizer INC. | $16.17 | 2024 | |
| Novo Nordisk INC | $15.32 | 2024 | Wegovy |
| Molnlycke Health Care US, LLC | $14.77 | 2024 | Mepilex Border Post-Op, Avance |
| Scynexis, INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerith Lucco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.